↓ Skip to main content

Agitated delirium associated with therapeutic doses of sustained-release bupropion

Overview of attention for article published in International Journal of Clinical Pharmacy, November 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
36 Mendeley
Title
Agitated delirium associated with therapeutic doses of sustained-release bupropion
Published in
International Journal of Clinical Pharmacy, November 2011
DOI 10.1007/s11096-011-9587-x
Pubmed ID
Authors

Diana R. Mack, Liza Barbarello-Andrews, Mei T. Liu

Abstract

We report a case of a patient initiated on therapeutic doses of sustained-release bupropion for the management of major depressive disorder who subsequently developed acute agitated delirium that required ICU level care. This patient's history was significant for alcohol and cannabis abuse but he was currently detoxified and beyond the withdrawal period. Throughout the course of treatment, all maintenance medications, including bupropion, were discontinued and the patient required escalating doses of benzodiazepines and typical antipsychotics to resolve symptoms. The patient's delirium subsided after approximately 5 days.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 36 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 3%
Unknown 35 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 19%
Student > Bachelor 6 17%
Researcher 6 17%
Other 5 14%
Librarian 2 6%
Other 2 6%
Unknown 8 22%
Readers by discipline Count As %
Medicine and Dentistry 18 50%
Psychology 4 11%
Nursing and Health Professions 3 8%
Social Sciences 2 6%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 3 8%
Unknown 5 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2012.
All research outputs
#18,306,425
of 22,665,794 outputs
Outputs from International Journal of Clinical Pharmacy
#867
of 1,071 outputs
Outputs of similar age
#195,462
of 239,473 outputs
Outputs of similar age from International Journal of Clinical Pharmacy
#11
of 15 outputs
Altmetric has tracked 22,665,794 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,071 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 239,473 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.